Strict new guidelines lay out a path to heritable human gene editing
By Tina Hesman Saey,
Science News [cites CGS's Katie Hasson]
| 09. 03. 2020
But scientists say making changes in DNA that can be passed on isn’t yet safe and effective
In 2018, Jiankui He (pictured) announced that he had edited genes in embryos to create two baby girls.
Gene editing to make heritable changes in human DNA isn’t yet safe and effective enough to make gene-edited babies, an international scientific commission says. But in a Sept. 3 report, the group laid out a road map for rolling out heritable gene editing should society decide that kind of DNA alteration is acceptable.
The International Commission on the Clinical Use of Human Germline Genome Editing formed after a Chinese scientist announced in 2018 that he had created two gene-edited baby girls, sparking outrage (SN: 11/27/18). In its first official weigh-in on the issue, the group lays out strict scientific criteria that would need to be met before heritable gene editing could be tried clinically. If countries can’t ensure that all of those criteria are met, heritable gene editing shouldn’t be approved, the commissioners say.
Still, some critics charge that even presenting such criteria is premature. The science should wait until society decides whether to allow gene editing that can...
Related Articles
By Rhys Blakely, The Times | 06.24.2025
Scientists have created fertile mice from male genetic material alone, a breakthrough that could one day open the door to human babies who inherit their genes from two fathers.
The experiment, led by Professor Yanchang Wei at Shanghai Jiao Tong...
By Angus Liu, Fierce Pharma | 06.16.2025
A second patient has died following treatment with Sarepta Therapeutics’ Elevidys, raising more doubts about the Duchenne muscular dystrophy (DMD) gene therapy’s safety profile.
Sarepta and its ex-U.S. partner Roche reported the death early Sunday. Like the first case, disclosed...
By Sophie Alexander and Ike Swetlitz, Bloomberg | 06.25.2025
A California-startup focused on genetically editing human embryos — a step toward creating so-called designer babies — is raising money as many of Silicon Valley’s ultra-rich turn their attention to one of the most controversial technologies in medicine.
Bootstrap Bio...
By Briana Contreras, Managed Healthcare Executive | 06.17.2025